Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World April 23, 2015 Tim Wogan	SiRNA treatment cures Ebola in monkeys The first laboratory trial demonstrating the effectiveness of an experimental drug against the strain of Ebola currently ravaging West Africa has been performed in rhesus monkeys.
Chemistry World May 29, 2013 Hayley Birch	Fast flu mapping without the sequencing Australian researchers showed that using data from flu virus proteins produced similar trees to those generated by genetic sequencing, suggesting a rapid-fire solution for identifying viruses during outbreaks.
Chemistry World January 22, 2013 Andrew Turley	Flu vaccine without the eggs approved Flublok from US biotech Protein Sciences has become the first flu vaccine made using an insect virus to win marketing approval in the US.
Chemistry World September 1, 2014 Maria Burke	Experimental Ebola drug 'impressive' in animal trials In the hunt for a treatment for Ebola, a new study has shown that monkeys given the experimental drug ZMapp all survived infection with the virus.
Popular Mechanics March 2006 Jeff Wise	Fighting Fire With Fire By recreating an extinct virus that killed as many as 50 million people, scientists race to defeat avian flu before it evolves into a deadlier form.
Popular Mechanics September 2006 Ben Harder	Seeking Immunity Pathogens like West Nile virus show no respect for borders. But a new class of vaccines may soon keep them in check.
Chemistry World June 9, 2008 Simon Hadlington	Artificial virus silences genes Scientists in Korea have created an artificial virus that can target the nucleus of cancer cells and knock out specific genes.
Chemistry World August 31, 2011 Hayley Birch	Smallpox vaccine virus puts cancer in its sights The results of a human cancer therapy trial show for the first time that tumors can be targeted and infected by engineered viruses, without damage to surrounding tissues.
Chemistry World April 16, 2009 Simon Hadlington	Mass spec pinpoints flu virus types Researchers in Australia have shown that exquisitely accurate mass spectrometry can be used to distinguish between different sub-types of the influenza virus
Chemistry World February 17, 2014 Helen Bache	Small molecules stop cervical cancer virus assembling Researchers in China have disrupted the life cycle of the leading cause of cervical cancer -- the human papilloma virus -- using a macrocyclic molecule called a pillarene.
Chemistry World December 3, 2014 Maria Burke	Ebola vaccine passes first safety hurdle The vaccine was developed collaboratively by scientists at the NIH's National Institute of Allergy and Infectious Diseases, and at Okairos, a biotechnology company acquired by GlaxoSmithKline.
Chemistry World August 5, 2015 Emma Stoye	Vaccine raises hopes of an end to Ebola A Phase III trial for a candidate Ebola vaccine has shown extremely encouraging results in Guinea, demonstrating complete protection for all those who were vaccinated.
Chemistry World November 25, 2015 Philippa Matthews	'Superballs' can block infection by Ebola virus Molecular 'superballs' have been created that can stop viruses infecting cells.
Chemistry World August 20, 2014 Maria Burke	Doctors turn to experimental Ebola treatments The emergency use of an experimental medicine is highly unusual, but the WHO has declared the Ebola outbreak a public health emergency of international concern.
AskMen.com Jacob Franek	Avian Influenza 101 Here is everything you need to now about avian influenza so that you can better protect yourself.
Bio-IT World November 2005	News Blast Applied Biosystems contributes 400,000 primers... Researchers have discovered the full genetic sequence of many different strains of the flu... Sigma-Aldrich launches Panorama Human Cancer Version 1 Protein Functional Microarray...
Pharmaceutical Executive December 1, 2005 Anthony Tao	The Avian Few: Is it Too Late for Pharma to Re-enter the Vaccine Fray? Small profit margins and high litigation risks drove most companies out of the vaccine business decades ago. As a possible pandemic looms, pharma re-enters the fray. Is it too late?
HHMI Bulletin Aug 2011 Cassandra Willyard	A Faster Knockout With a virus, a needle, and an ultrasound machine, researchers have drastically cut the time it takes to disable a gene in mice.
Chemistry World October 23, 2014 Rebecca Trager	US agency fast-tracks Ebola vaccine development The US Department of Health and Human Services is fast-tracking tests on an Ebola vaccine by providing $5.8 million under a one-year contract with the Maryland-based biotech company Profectus BioSciences
Information Today August 28, 2014	National Library of Medicine Launches Ebola Resources Webpage This webpage will help organizations and individuals who are working to combat the virus in West Africa or those who are friends and family of people in the affected region.
Chemistry World July 18, 2014 Melissae Fellet	Molecular computer calculates Ebola diagnosis A molecular computer could one day simplify analysis of biomedical assays like those used to diagnose Ebola, researchers say.
Technology Research News October 20, 2004 Eric Smalley	Biochip spots single viruses A detector recently built from nanowire transistors can identify individual virus particles in real time in unpurified samples. Labs-on-a-chip based on the device could be used to monitor diseases.
Chemistry World December 19, 2007 Simon Hadlington	Snapshot of Proteins Linked to Autism Researchers in France and the US have caught on camera the gentle embrace between two proteins that sit on either side of the junction between nerve cells. It's this short circuit that has thought to cause some types of autism.
Wired September 2002 Amanda Griscom	Take These Genes and Call Me in the Morning Gene vaccines may be relatively new, but they're the logical outgrowth of two familiar strands of medical science.
Fast Company June 2015	Meet Ebola's Soft-Spoken, Plant-Loving Arch Nemesis A professor at Arizona State University, Arntzen is considered the godfather of a growing field of research sometimes called "pharming": engineering plants to produce specialized vaccines and other drugs.
HHMI Bulletin Aug 2010 Brian Vastag	Targeting Machupo Virus A supportive mentor and a Gilliam fellow find a new drug target against a virus that strikes hardest in poor, rural regions.
Popular Mechanics January 22, 2010 Allie Townsend	Does Fringe's Virus Eradication Plan Hold Up? Is the show's disease from the deep possible? "No," says Dr. William Blattner, director of The Institute of Human Virology. "But it does make for good TV."
Chemistry World November 25, 2008 James Urquhart	Virus revealed by flipping lipid A drug that flags up virus-infected cells for destruction by the body's own immune system could lead to new, broad-spectrum anti-viral treatments, say US scientists.
Chemistry World October 1, 2014 Michael Gross	Viruses melt 'glassy' DNA US Researchers have identified the factors that enable viral DNA to turn from solid to liquid, which allows them to infect host cells. They say the process could become a target for new antiviral therapies.
Industrial Physicist	Biomimetic Nanotechnology Although biomimetic nanotechnology is in its infancy, with no applications yet reaching commercialization, the barriers in some cases lie mainly in scaling up production processes to industrial levels.
Chemistry World February 28, 2011 Hayley Birch	Protein nanotubes trap viruses Japanese researchers have used nanotubes made from human blood proteins to trap hepatitis B virus. They say their work lays the foundations for a new chemistry of protein-based nanotubes with biomedical applications.
Chemistry World January 19, 2015 Maria Burke	Roadmap to fast track Ebola vaccine development A global group of experts has developed a 'roadmap' to help the health community fast track an Ebola vaccine.
Bio-IT World October 10, 2003 Jeffrey Skolnick	Protein Structure Prediction in Drug Discovery Indications are that structure prediction can assist in the automated assignment of proteins to known pathways.
Pharmaceutical Executive October 1, 2014 Jill Wechsler	Ebola Crisis Challenges Pharma R&D Companies gain support and pressure to deliver new treatments for spreading outbreak.
BusinessWeek November 24, 2003 John Carey	Barring The Door Against AIDS A new generation of drugs focuses on keeping the virus from entering cells.
Scientific American February 27, 2006 Charles Q. Choi	Going to Bat Long known as vectors for rabies, bats may be the origin of some of the most deadly emerging viruses. Knowledge that bats can carry dangerous viruses could work to prevent epidemics.
Managed Care February 2005 Jack McCain	Managed Care (and Everyone Else) Unprepared for the Next Killer Flu Could avian flu give rise to a pandemic that might rival the fearsome Spanish flu? Is the nation ready? Health plans may be called upon to administer vaccinations and identify high-risk patients, but what about he millions of Americans who lack health insurance?
PC World November 16, 2000 Kim Zetter	Freeze! Drop That Download! From toughening laws to making virus writing seem uncool, industry and government are trying everything to stop virus writers...
Chemistry World October 16, 2014 Amy Middleton-Gear	New test accelerates herpes detection A new assay for spotting the virus responsible for cold sores has been developed by scientists in Ireland.
Chemistry World October 2, 2012 Fiona McKenzie	Protein sorting within cells US scientists have used magnetic nanoparticles with specific ligands to latch on to and visualize specific proteins in living cells.
Bio-IT World June 12, 2002 Mark D. Uehling	Putting Proteins in Their Place Will a 'periodic table' of proteins help classify the ungainly beasts?
Unix Insider January 2001 Sandra Henry-Stocker	Understanding viruses What exactly is a virus, how does it work, and how can you protect your system from one? The author explains the difference between viruses and worms, and why keeping up with and preventing them is so difficult...
HHMI Bulletin February 2011	Viral Outbreak: The Science of Emerging Disease Almost 200 high school students from across the Washington, D.C., area learned firsthand how scientists study the emergence and spread of these and other deadly viruses in December at the 2010 Holiday Lectures on Science.
The Motley Fool March 16, 2006 Rich Duprey	Avian Flu Ruffling Feathers Roche Pharmaceuticals boosts anti-flu drug production to quiet calls for generics. While the situation bears watching for now, it's not necessarily something for investors to get their feathers ruffled about.
PC World October 13, 2000 Kim Zetter	How It Works: Viruses They're the "common cold" for computers; we'll show you how they operate and how to protect your PC...
Chemistry World October 27, 2014 Tim Wogan	Folding rules used to build unnatural proteins Scientists in the UK and US have designed and synthesized unnatural protein structures, using theoretical calculations to explore the factors affecting protein folding and stability.
Pharmaceutical Executive February 1, 2007 Bradley Thompson	Virus as Viable Drug Coincidence or phenomena? The reovirus is Mother Nature's own cancer-killer.
Chemistry World November 13, 2014 Katrina Kramer	Persuading proteins to form porous polyhedra Researchers in the US have designed a hollow cube out of naturally occurring proteins, something that was previously only possible with DNA.
Industrial Physicist Aug/Sep 2003 Ineke Malsch	Protein research calls for advanced instruments The science of protein interactions is becoming a major tool in biomedical and drug development research. Carrying out and advancing such studies more efficiently and effectively, however, will require new, cutting-edge instrumentation.
Chemistry World July 6, 2012 Steve Down	Flu fighters are wired Scientists from Peking University and the University of Science and Technology, Beijing, China, have devised a test which uses a biosensor made from a grid of silicon nanowires which have been functionalized with influenza A antibodies to trap proteins from the virus.